Relapsing fever future or investigational therapies: Difference between revisions
| Line 2: | Line 2: | ||
{{Relapsing fever}} | {{Relapsing fever}} | ||
==Overview== | ==Overview== | ||
Currently, no vaccine against relapsing fever is available, but research continues. Developing a vaccine is very difficult because the spirochetes avoid the immune response of the infected person (or animal) through antigenic variation (changing its surface proteins). | |||
==Future or investigational therapies== | ==Future or investigational therapies== | ||
Revision as of 23:57, 10 August 2020
|
Relapsing fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Relapsing fever future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Relapsing fever future or investigational therapies |
|
Relapsing fever future or investigational therapies in the news |
|
Blogs on Relapsing fever future or investigational therapies |
|
Risk calculators and risk factors for Relapsing fever future or investigational therapies |
Overview
Currently, no vaccine against relapsing fever is available, but research continues. Developing a vaccine is very difficult because the spirochetes avoid the immune response of the infected person (or animal) through antigenic variation (changing its surface proteins).
Future or investigational therapies
Currently, no vaccine against relapsing fever is available, but research continues. Developing a vaccine is very difficult because the spirochetes avoid the immune response of the infected person (or animal) through antigenic variation (changing its surface proteins).